The mechanism underlying the inhibition of the liver mitochondrial oxidation of glutamate by the carcinogen N-2-fluorenylacetamide.
D015073:2-Acetylaminofluorene; D002273:Carcinogens / Q000494:pharmacology*; D005449:Fluorenes / Q000031:analogs & derivatives; D005971:Glutamates / Q000378:metabolism*; D018698:Glutamic Acid; D008099:Liver / Q000378:metabolism*; D008928:Mitochondria; D010084:Oxidation-Reduction
D002273:Carcinogens; D005449:Fluorenes; D005971:Glutamates; D018698:Glutamic Acid; C041509:fluorene; D015073:2-Acetylaminofluorene
CARCINOGENS/effects; FLUORENE/related compounds; GLUTAMATES/metabolism; LIVER/metabolism; MITOCHONDRIA